People taking immunosuppressant produce weaker, shorter-lived antibodies after COVID-19 vaccination – News-Medical.net

People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors -; a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions -; generated less powerful and shorter-lived antibodies against the…

Click here to view the original article.